Welcome Guest!  Login | Register | Help | Survey
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
INSM [NASD]
Insmed Incorporated
Healthcare - Biotechnology - USA
Index- P/E0.89 EPS (ttm)0.91 Insider Own3.69% Shs Outstand130.21M Perf Week-6.90%
Market Cap105.47M Forward P/E- EPS next Y- Insider Trans- Shs Float125.40M Perf Month5.19%
Income112.08M PEG- EPS next Q- Inst Own19.82% Short Float2.57% Perf Quarter10.96%
Sales10.43M P/S10.11 EPS this Y26.30% Inst Trans18.67% Short Ratio5.22 Perf Half Y-17.35%
Book/sh0.92 P/B0.88 EPS next Y- ROA168.82% Target Price2.00 Perf Year84.09%
Cash/sh0.94 P/C0.86 EPS next 5Y- ROE184.07% 52W Range0.41 - 2.57 Perf YTD5.19%
Dividend- P/FCF- EPS past 5Y0.00% ROI179.59% 52W High-68.38% Beta-0.39
Dividend %- Quick Ratio34.19 Sales past 5Y139.01% Gross Margin- 52W Low98.22% ATR0.04
Employees97 Current Ratio34.19 Sales Q/Q-39.20% Oper. Margin-117.45% RSI (14)47.55 Volatility4.37% 5.25%
OptionableNo Debt/Eq0.00 EPS Q/Q93.44% Profit Margin1074.18% Rel Volume0.34 Prev Close0.81
ShortableYes LT Debt/Eq0.00 EarningsNov 06 BMO Payout0.00% Avg Volume617.52K Price0.81
Recom1.00 SMA20-3.48% SMA501.71% SMA200-21.81% Volume101,196 Change0.33%
16-Mar-07Reiterated CE Unterberg Towbin Buy $3 → $2
07-Mar-07Downgrade Lazard Capital Buy → Hold
31-Jan-10 04:58AM  Under the Radar Developments at Insmed at Seeking Alpha
06-Jan-10 03:35PM  The Schloss Screen for 2010 RealMoney by TheStreet.com
05-Jan-10 08:55AM  Old School Value Stock Portfolio Performance 2009 at Seeking Alpha
18-Dec-09 03:43PM  Buy a Company, Get the Plant for Free at Motley Fool
14-Dec-09 04:12AM  8 Cheap Stocks Trading Below Net Net Working Capital at Seeking Alpha
07-Dec-09 04:17PM  4 More Stocks on Wall Street's Dollar Menu at Motley Fool
03-Dec-09 05:13AM  Portfolio Performance Update: November 2009 at Seeking Alpha
13-Nov-09 09:05AM  INSMED INC Financials EDGAR Online Financials
09-Nov-09 09:16AM  Insmed Still Looks Very Undervalued at Seeking Alpha +6.49%
06-Nov-09 08:36AM  INSMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online +5.48%
08:30AM  Insmed Incorporated Earnings Call scheduled for 8:30 am ET today CCBN
08:15AM  Specialty Pharma Stock Picks From David Amsellem Of Piper Jaffray Wall Street Transcript
07:07AM  Q3 2009 Insmed Incorporated Earnings Release - Before Market Open CCBN
07:00AM  Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2009 PR Newswire
03-Nov-09 06:02AM  Old School Value Stock Portfolio Performance October 2009 at Seeking Alpha
22-Oct-09 08:00AM  Insmed To Host Third Quarter 2009 Conference Call PR Newswire
20-Oct-09 08:14AM  "Best In Class" Formulation Of Fentanyl Seen As Breakthrough Treatment By Ladenburg Thalmann Analyst Wall Street Transcript
04-Oct-09 05:23AM  Portfolio Update: Holdings, Performance at Seeking Alpha
18-Sep-09 02:21PM  Sirius Breaks the Buck at Motley Fool
16-Sep-09 05:03PM  INSMED INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transf EDGAR Online
04:15PM  Insmed Receives NASDAQ Deficiency Notice Relating to Minimum Bid Price PR Newswire
18-Aug-09 04:18AM  As Market Drops, It's Time to Buy at Seeking Alpha
16-Aug-09 08:00PM  Second Quarter 10Q for Insmed Incorporated WILink
13-Aug-09 09:06AM  INSMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
08:30AM  Insmed Incorporated Earnings Call scheduled for 8:30 am ET today CCBN
07:00AM  Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 PR Newswire
12-Aug-09 11:25AM  5 More Stocks on Wall Street's Dollar Menu at Motley Fool
31-Jul-09 08:00AM  Insmed to Host Second Quarter 2009 Conference Call PR Newswire
28-Jul-09 03:14AM  Insmed's Monday Morning Press Release: Reading Between the Lines at Seeking Alpha
27-Jul-09 09:20AM  UPDATE - Insmed stops supplying Iplex to new patients at Reuters -7.48%
08:20AM  INSMED INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:00AM  Insmed Provides Update on Supply of IPLEX(TM) PR Newswire
20-Jul-09 04:10AM  Insmed's Good End of the Deal at Seeking Alpha
14-Jul-09 09:00AM  BenchmarkJournal.com Free Analyst Review for LULU, GMCR, INSM, FTWR, AVNR and CLNE Marketwire +5.88%
09-Jul-09 11:23AM  How Majesco Helped Me Win with Insmed: Lessons in Speculative Investing at Seeking Alpha
02-Jul-09 05:01PM  INSMED INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
01-Jul-09 03:26AM  5 More Stock Briefs at Seeking Alpha
30-Jun-09 08:00AM  Biotech Calendar: Key Clinical Trial Dates at TheStreet.com -8.26%
08:00AM  Insmed Announces Addition to the Russell 3000(R) Index PR Newswire
27-Jun-09 05:46AM  [$$] Charting The Market at Barron's Online
26-Jun-09 06:37PM  U.S. Holds Promise In Biosimilars Market Investor's Business Daily +6.48%
04:21PM  TradingMarkets 7 Stocks You Need to Know for Monday TradingMarkets.com
08:55AM  INSMED INC Files SEC form 8-K, Unregistered Sale of Equity Securities EDGAR Online
05:42AM  FDA Calendar Updates: AZN, BMY, OSUR, CPD, INSM, HLUKY at Seeking Alpha
25-Jun-09 06:07PM  Lennar, Boston Scientific, Imax are big movers AP -53.65%
09:56AM  Insmed shares plummet on Iplex study results AP
09:12AM  UPDATE - Insmed drug fails in genetic disorder study, shrs tank at Reuters
08:00AM  Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy PR Newswire
07:58AM  InPlay: Insmed trading halted - news pending Briefing.com
20-Jun-09 08:00AM  The Best Stocks for the Next 4 Years at Motley Fool
18-Jun-09 03:13AM  7 More Stock Briefs at Seeking Alpha +12.04%
16-Jun-09 07:13AM  Insmed CEO resigns because of health condition AP
15-Jun-09 07:38PM  [video] La-Z-Boy Surprises at Forbes.com
07:12PM  [$$] Insmed CEO Steps Down Over Health at The Wall Street Journal Online
04:45PM  Insmed CEO Resigns Due to Health Concerns PR Newswire
12-Jun-09 05:26PM  Merck spent $1.5M in 1Q lobbying on health reform AP
08-Jun-09 02:44PM  5-Star Stocks on the Upswing at Motley Fool +8.56%
07:09AM  Insmed Stock Rising on High Volume, But Still a Good Buy at Seeking Alpha
03-Jun-09 04:28PM  INSMED INC Files SEC form 8-K, Unregistered Sale of Equity Securities EDGAR Online
22-May-09 04:08PM  INSMED INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
18-May-09 05:19AM  Will Insmed's IPLEX Meet Expectations? at Seeking Alpha +14.71%
14-May-09 06:33AM  Pending Clinical Trial Results: Ten Extreme Trades at Seeking Alpha
02:56AM  FDA, Clinical Trial Updates: Insmed, Jazz Pharma Await Key Results at Seeking Alpha
13-May-09 06:31PM  Earnings roundup: URS, Jack in the Box AP -7.25%
03:54PM  Insmed swings to 1Q profit on Merck deal AP
08:56AM  INSMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
08:30AM  Insmed Incorporated Earnings Call scheduled for 8:30 am ET today CCBN
07:07AM  Q1 2009 Insmed Incorporated Earnings Release - Before Market Open CCBN
07:00AM  Insmed Announces First Quarter 2009 Financial Results PR Newswire
05-May-09 04:31PM  INSMED INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:00AM  Insmed Regains NASDAQ Compliance PR Newswire
23-Apr-09 08:00AM  Insmed to Host First Quarter 2009 Conference Call PR Newswire
19-Apr-09 10:00AM  Why We Love Wild Penny Stocks at Motley Fool
17-Apr-09 05:16PM  Analysts look for news on Merck tie-up, key drugs AP +14.29%
02-Apr-09 06:01AM  INSMED INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits EDGAR Online
31-Mar-09 05:11PM  INSMED INC Files SEC form 10-K, Annual Report EDGAR Online
05:06PM  Insmed Completes Sale of Follow-On Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million PR Newswire
30-Mar-09 05:30PM  Insmed Announces Agreement With IDIS to Manage Expanded Access Programs for IPLEX(TM) PR Newswire
25-Mar-09 08:00AM  Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule PR Newswire
19-Mar-09 04:37PM  INSMED INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
11-Mar-09 08:30AM  Insmed Incorporated Earnings Call scheduled for 8:30 am ET today CCBN -12.00%
07:28AM  INSMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:07AM  Q4 2008 Insmed Incorporated Earnings Release - Before Market Open CCBN
07:00AM  Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results PR Newswire
10-Mar-09 03:31PM  UPDATE - US allows Lou Gehrig's patients to try Insmed drug at Reuters +11.11%
01:39PM  Insmed Announces FDA Issues Statement Regarding Position on Allowing Patients With ALS Access to IPLEX(TM) Under an IND PR Newswire
12:49PM  UPDATE - US allows Lou Gehrig's patients to try Insmed drug at Reuters
11:43AM  US allows Lou Gehrig's patients to try Insmed drug at Reuters
26-Feb-09 08:00AM  Insmed to Host Fourth Quarter and Full-Year 2008 Conference Call PR Newswire +12.66%
13-Feb-09 01:18PM  The Easy Way to Develop Drugs at Motley Fool +11.76%
06:06AM  INSMED INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition o EDGAR Online
12-Feb-09 09:12PM  [$$] Merck to Buy Drugs, Plant From Insmed at The Wall Street Journal Online +54.55%
01:43PM  UPDATE - Merck to pay $130 mln to Insmed in biologics deal at Reuters
07:54AM  Merck will buy Insmed biosimilars for $130 million AP
07:38AM  Merck to buy Insmed's follow-on biologics portfolio at MarketWatch
07:32AM  UPDATE - Merck to pay $130 mln to Insmed in biologics deal at Reuters
07:00AM  Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million PR Newswire
07:00AM  Merck & Co., Inc. Acquires Biologic Manufacturing Capabilities and Developmental Follow-on Biologics Portfolio from Insmed Business Wire
21-Jan-09 08:00AM  Insmed and Premacure Announce European Orphan Designation for IPLEX(TM) in Retinopathy of Prematurity in Infants PR Newswire +10.20%
30-Dec-08 08:34AM  INSMED INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transf EDGAR Online
Insmed Incorporated, a development stage company, engages in the development of recombinant protein drug. The company's primary product includes IPLEX, a complex of recombinant human IGF-1 and its binding protein IGFBP-3 for use in the treatment of several serious medical conditions, as well as conducting a phase III enabling clinical trial for investigating IPLEX as a treatment for myotonic muscular dystrophy. Insmed also engages in various oncology programs, including INSM-18, an orally available small molecule tyrosine kinase inhibitor that has demonstrated selective inhibition of IGF-1 and human epidermal growth factor receptor; and rhIGFBP-3, which is in early clinical development stage for the treatment of breast, prostate, liver, ovarian, and colon cancers. The company also provides Expanded Access Program in Italy to offer IPLEX to physicians for use in their patients with amyotrophic lateral sclerosis. It has a license to Pharmacia AB's portfolio of regulatory filings pertaining to rhIGF; and an agreement with NAPO Pharmaceuticals that gives NAPO the right to develop, manufacture, and commercialize masoprocal products for various indications relating to diabetes, cardiac disease, vascular disease, metabolic disease, and syndrome X. The company was founded in 1999 and is headquartered in Richmond, Virginia.